ArticleJournal of general internal medicine2014
Abdominal aortic aneurysm screening: how many life years lost from underuse of the medicare screening benefit?
Article in Journal of general internal medicine, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
10 citing papers in PubMed, 27 citations in OpenAlex.
- Validation of Family Medicine Point-of-Care Ultrasound Screening (POCUS) for Abdominal Aortic Aneurysm.Journal of the American Board of Family Medicine : JABFM · 2026Observational
- Burden and Trends of Aortic Aneurysms in Individuals Aged 55 and Older from 1990 to 2021: A Systematic Analysis of the Global Burden of Disease Study 2021.Global heart · 2026Article
- Focus on the Most Common Paucisymptomatic Vasculopathic Population, from Diagnosis to Secondary Prevention of Complications.Diagnostics (Basel, Switzerland) · 2023Review
- Abdominal aortic aneurysm monitoring via arterial waveform analysis: towards a convenient point-of-care device.NPJ digital medicine · 2022Article
- Impact of Implicit Abdominal Aortic Aneurysm Screening in the Veterans Affairs Health Care System Over 10 Years.Journal of the American Heart Association · 2022Article
- Overview of screening eligibility in patients undergoing ruptured AAA repair from 2003 to 2019 in the Vascular Quality Initiative.Journal of vascular surgery · 2022Observational
- Abdominal aortic aneurysm screening: concepts and controversies.Cardiovascular diagnosis and therapy · 2018Review
- Abdominal aortic aneurysm screening program using hand-held ultrasound in primary healthcare.PloS one · 2017Article
- Capsule commentary on Olchanski et al., abdominal aortic aneurysm screening: how many life years lost from underuse of the medicare screening benefit?Journal of general internal medicine · 2014Article
- Screening Older Adult Men for Abdominal Aortic Aneurysm: A Scoping Review.American journal of men's healthArticle
Corrections and comments
- Commented on by
Authors and funding
4 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundSince 2007, Medicare has provided one-time abdominal aortic aneurysm (AAA) screening for men with smoking history, and men and women with a family history of AAA as part of its Welcome to Medicare visit.
objectiveWe examined utilization of the new AAA screening benefit and estimated how increased utilization could influence population health as measured by life years gained. Additionally, we explored the impact of expanding screening to women with smoking history.
designAnalysis of Medicare claims and a simulation model to estimate the effects of screening, using published data for parameter estimates.
settingAAA screening in the primary care setting. PATIENTS: Newly-enrolled Medicare beneficiaries aged 65 years, with smoking history or family history of AAA. MAIN MEASURES: Life expectancy, 10-year survival rates. KEY
resultsMedicare data revealed low utilization of AAA screening, under 1% among those eligible. We estimate that screening could increase life expectancy per individual invited to screening for men with smoking history (0.11 years), with family history of AAA (0.17 years), and women with family history (0.08 years), and smoking history (0.09 years). Average gains of 131 life years per 1,000 persons screened for AAA compare favorably with the grade B United States Preventive Services Task Force (USPSTF) recommendation for breast cancer screening, which yields 95-128 life years per 1,000 women screened. These findings were robust over a range of scenarios. LIMITATIONS: The simulation results reflect assumptions regarding AAA prevalence, treatment, and outcomes in specific populations based on published research and US survey data. Published data on women were limited.
conclusionsThe Welcome to Medicare and AAA screening benefits have been underutilized. Increasing utilization of AAA screening would yield substantial gains in life expectancy. Expanding screening to women with smoking history also has the potential for substantial health benefits.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.